Generated: April 29, 2017
|Title:||2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations|
|Abstract:||The present invention relates to new formulations containing one or more estrogens and 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole compounds which are useful as estrogenic agents, as well as pharmaceutical compositions and methods of treatment utilizing these compounds, which have the general structures below: ##STR00001##|
|Inventor(s):||Pickar; James H (Springfield, PA), Komm; Barry S (Havertown, PA)|
|Assignee:||Wyeth LLC (New York, NY)|
|Patent Claims:||1. A pharmaceutical composition comprising an oral dosage comprising a tablet or capsule for the treatment of post-menopausal syndrome comprising conjugated estrogens, in the amount of about 0.3 mg, to about 2.5 mg and 1-[4-(2-Azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxy-phenyl)-3-methyl-1H-indo- l-5-ol or a pharmaceutically acceptable salt thereof, in the amount of from about 1 mg to about 150 mg, and a pharmaceutically acceptable carrier or excipient.|
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.